Genmab A (GMAB) Change in Inventory (2023 - 2026)
Genmab A (GMAB) posted Change in Inventory of -$3.0 million for Q1 2026, up 40.0% on a QoQ basis from -$5.0 million in Q3 2025, and little changed year-over-year from -$3.0 million in Q1 2025.
Genmab A (GMAB) Change in Inventory (2023 - 2026) Analysis & Trends
Genmab A's Change in Inventory history runs 4 years deep, the most recent figure standing at -$3.0 million for Q1 2026.
- Quarterly Change in Inventory changed 0.0% year-over-year to -$3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$15.0 million (down 400.0% YoY) and the FY2025 annual result came in at -$9.0 million, down 800.0% from the prior year.
- Change in Inventory was -$3.0 million for Q1 2026 at Genmab A, up from -$5.0 million in the prior quarter.
- Across five years, Change in Inventory topped out at $3.0 million in Q2 2024 and bottomed at -$8.0 million in Q4 2023.
- A 4-year average of -$3.3 million and a median of -$3.0 million in 2025 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2024 — Change in Inventory surged 87.5% — and 2025, when it plunged 233.33%.
- Genmab A's Change in Inventory stood at -$8.0 million in 2023, then jumped by 87.5% to -$1.0 million in 2024, then slumped by 400.0% to -$5.0 million in 2025, then soared by 40.0% to -$3.0 million in 2026.
- Business Quant data shows GMAB's Change in Inventory at -$3.0 million in Q1 2026, -$5.0 million in Q3 2025, and -$4.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Genmab A | 1.89 Bn | 366.92 Mn | 831.00 Mn | -3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.00 Mn |
| Mar 31, 2026 | -3.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Jun 30, 2025 | -4.00 Mn |
| Jun 30, 2025 | -4.00 Mn |
| Mar 31, 2025 | -3.00 Mn |
| Mar 31, 2025 | -3.00 Mn |
| Dec 31, 2024 | -1.00 Mn |
| Dec 31, 2024 | -1.00 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | -7.00 Mn |
| Mar 31, 2024 | -7.00 Mn |
| Dec 31, 2023 | -8.00 Mn |
| Dec 31, 2023 | -8.00 Mn |